Sysmex America Inc, Lincolnshire, Ill, and Sysmex Corp, Kobe, Japan, report the FDA has cleared the Sysmex® XN-Series Hematology Analyzers.
The XN-Series enables labs of any size to implement advanced clinical parameters, including an all-new fluorescent platelet channel for immature platelet fraction to aid in the differential diagnosis of thrombocytopenia.
The scalable, series-wide compact design delivers a small footprint that optimizes speed and functionality and provides automation benefits.
The series includes the Sysmex XN-1000™, Sysmex XN-2000™, and Sysmex XN-3000™.
The Sysmex XN-9000™, coupled with tube sorting and archiving, HbA1c automation and powered by Intelligent Automation from the Sysmex WAM™, carries the Lavender Top Management® capabilities introduced by Sysmex for the management of more than 90% of most lab’s lavender top tubes.
The hematology analyzers are available for sale in the United States, Canada, and Latin America.
[Source: Sysmex]
